Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.
Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check19 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedOn November 19, 2024, new content was added, while a significant section detailing data download options and study information was removed on July 18, 2024.SummaryDifference14%
- Check48 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and an extensive selection of data fields for studies.SummaryDifference16%
- Check55 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
- Check63 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.6%
Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.